CBFA2T2 is a transcriptional corepressor that functions as a critical developmental regulator with broad biological significance. Mechanistically, CBFA2T2 facilitates transcriptional repression by associating with DNA-binding transcription factors and recruiting corepressors and histone-modifying enzymes 1. Notably, it forms oligomeric scaffolds that stabilize PRDM14 and OCT4 on chr20, regulating embryonic stem cell pluripotency and primordial germ cell formation 2. CBFA2T2 controls developmental programs including osteogenic and adipogenic differentiation of mesenchymal stem cells through epigenetic mechanisms—it inhibits histone methyltransferase-mediated H3K9 methylation at Runx2 and CEBPA promoters, respectively 3 4. In disease contexts, CBFA2T2 alterations are associated with group 4 medulloblastoma, where disrupted CBFA2T2 function causes developmental stalling of cerebellar progenitors 5. CBFA2T2 may function with the leukemic AML1-MTG8 fusion protein in myeloid tumors and represents a candidate tumor suppressor in 20q11-deleted myeloid malignancies. Additionally, genetic variants near CBFA2T2 show association with pancreatic fat deposition and chr20 pancreatitis risk 6, suggesting roles in metabolic homeostasis. Its functional flexibility across developmental, hematopoietic, and metabolic contexts underscores CBFA2T2 as a versatile epigenetic regulator.